生物合成过程中莫那克林J的高效液相色谱法测定方法

包如胜 孙鹏 杨仲毅 杨勇 王然 李娜

中国药学杂志 ›› 2012, Vol. 47 ›› Issue (7) : 543-546.

PDF(978 KB)
PDF(978 KB)
中国药学杂志 ›› 2012, Vol. 47 ›› Issue (7) : 543-546.
论著

生物合成过程中莫那克林J的高效液相色谱法测定方法

  • 包如胜,孙鹏,杨仲毅,杨勇,王然,李娜
作者信息 +

HPLC Analysis of Monacolin J in Biosynthesis

Author information +
文章历史 +

摘要

目的 建立辛伐他汀生物合成过程中的莫那克林J 的HPLC测定方法。方法 色谱柱填料为C18多孔微粒键合硅胶,流动相为0.1%磷酸-乙腈(30∶70),流速为1 mL· min-1 ,检测波长238 nm;用HPLC控制洛伐他汀发酵液经碱裂解制备的莫那克林J及土曲霉基因改良工程菌直接发酵得到的莫那克林J含量。结果 开环莫那克林J在10~500 μg·mL-1内线性良好,r为0.999 8;经HPLC检测,洛伐他汀发酵液经碱裂解后提取得到莫那克林J开环酸的含量为92%,收率为96.24%,而土曲霉基因改良工程菌发酵液中则残留较多的洛伐他汀,与莫那克林J比例约为1.1∶1.0。结论 本实验建立的方法可以将莫那克林J、辛伐他汀及洛伐他汀的开环形式与闭环形式完全分开,适合用于辛伐他汀生物合成过程莫那克林J的研究。

Abstract

OBJECTIVE To establish an HPLC analysis method of monacolin J(MJ). METHODS MJ sample was analyzed with Hypersil C18 HPLC column. The mobile phase was composed of 0.1% H3PO4 and acetonitrile (30∶70) with flow rate of 1.0 mL·min-1, and the detection wavelength was 238 nm. Monacolin J samples produced from lovastatin fermentation mycelia and engineered Aspergilus terreus were analyzed. RESULTS The calibration curve of monacolin J was linear in the range of 10-500 μg·mL-1 with r of 0.999 8. The purity of crystaline monacolin J from lovastatin fermentation mycelia was 92%, and the purification yield was 96.24%. Meanwhile the engineered Aspergilus terreus produced lovastatin and monacolin J at the ratio of about 1.1∶1.0. CONCLUSION This HPLC method can separate lactone form and acid form of monacolin J, lovastatin and simvastatin very well. This HPLC method can be effectively used in monacolin J research of simvastatin biosynthesis.

关键词

莫那克林J / 辛伐他汀 / 洛伐他汀 / 高效液相色谱法 / 生物合成

Key words

monacolin J / simvastatin / lovastatin J / HPLC / biosynthesis

引用本文

导出引用
包如胜 孙鹏 杨仲毅 杨勇 王然 李娜. 生物合成过程中莫那克林J的高效液相色谱法测定方法[J]. 中国药学杂志, 2012, 47(7): 543-546
HPLC Analysis of Monacolin J in Biosynthesis[J]. Chinese Pharmaceutical Journal, 2012, 47(7): 543-546

参考文献


[1] PLOSKER G L, MCTAVISH D. Simvastatin: a reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia [J]. Drugs, 1995,50:334-363.
[2] FRANS V D, MARIA L J, PHILOMINA V H, et al. Process for producing simvastatin and/or its derivatives [P]. WO:9945003,1999-09-10.
[3] KOBE N T, KAKOGAWA K I. Process for producing simvastatin [P]. US: 6331641, 2001-12-18.
[4] ZHU Z Y, WU T Z, MOU L. Synthesis of simvastatin [J]. Zhejiang Chemical Industry(浙江化工),2002,33(1):49-55.
[5] TANG Y, XIE X K. Methods and materials for making simvastatin and related compounds[P]. WO2007/139871A2,2007-06-12.
[6] YANG Z Y, GAN C H. Biosynthesis of simvastatin [J]. Chin J Biotechnol (生物工程学报),2008,24(3):349-354.
[7] JAEHEON L. Process for the preparation of simvastatin[P]. WO: 2003/057684,2003-07-17
[8] XIE X K, WATANABE K, WOJCICKI W A, et al. Biosynthesis of lovastatin analogs with a broadly specific acyltransferase [J]. Chem Biol, 2006,13:1161-1169.

基金

国家“重大新药创制”科技重大专项(2008ZX09204-008)
PDF(978 KB)

Accesses

Citation

Detail

段落导航
相关文章

/